New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2018, Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
View latest version (2018)Bibliographic Info
GuidelineAntiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach 2010 revision
Year of Publication2010
Issuing InstitutionWHO
Recommendation
Status
Retired
Recommended in favor
Strong
Certainty of evidence
Moderate
For children between 12 and 24 months of age, not exposed to non-nucleoside reverse transcriptase inhibitor (NNRTI) , start ART with nevirapine (NVP) + 2 nucleoside reverse transcriptase inhibitor (NRTI)